abstract |
The pyrazole compound of the present invention is represented by the following general formula (I). The pyrazole compound of the present invention or a salt thereof or a solvate thereof strongly inhibits liver glycogen phosphorylase. Therefore, it is useful as a therapeutic or preventive agent for diabetes. (In the formula, each symbol is as described in the specification.) |